Toggle navigation
Home
Search
Services
Blog
Contact
About
Advanced Development of Anthim
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optimizing Trial Readiness for Adrenomyeloneuropathy
Transfusion Medicine/Hemostasis Trail Site at Psbc
Ocular Hypertension Treatment Study (OHTS)
Mechanisms in CNS myelination: Role of PD-Ialpha/ATX
Epidemiology of Hormones and Osteoporosis
Recently added grants:
Regulation of Allergen-Induced Airway Pathophysiology by Versican
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
A Novel Probiotic-Based Nanobody Delivery Platform
Mechanisms of Dopamine Action in Learning: Implications for Addiction
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700035C-2-0-1
Application #
7571058
Study Section
Project Start
2007-09-28
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Advanced Development of Anthim
/ Elusys Therapeutics, Inc.
$883,563
NIH 2007
N01 AI
Advanced Development of Anthim
/
Comments
Be the first to comment on this grant